The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 844.00
Ask: 846.00
Change: 4.00 (0.48%)
Spread: 2.00 (0.237%)
Open: 845.00
High: 847.00
Low: 839.00
Prev. Close: 838.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Interim Trading Update

22 Jul 2019 07:00

RNS Number : 1956G
JTC PLC
22 July 2019
 

22 July 2019

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Pre-close Interim Trading Update

 

 

JTC, a global provider of fund, corporate and private wealth services to institutional and private clients, today issues the following trading update in advance of its interim results for the six months ended 30 June 2019.

 

 

The Company has performed well throughout the first half of the year in both divisions and continues to deliver on its strategic and financial objectives, maintaining good momentum from 2018. As a result the Board expects that interim results will be in line with management expectations and guidance given at the prior full year results. The Board continues to see opportunities for both organic and inorganic growth in the second half of the year and beyond.

Nigel Le Quesne, CEO of JTC PLC, said:

 

"We have built on the results delivered in 2018 and carried good momentum into the first half of 2019. Both divisions have performed well and we have made solid progress against our strategic objectives and guidance provided, including net organic growth of 8-10% and underlying EBITDA margin of 30-35%. Cash conversion in the first half of the year has been particularly strong, supporting a pro forma net debt to EBITDA ratio within our target range of 1.5x-2.0x. Integration of Van Doorn (Netherlands), Minerva (multi jurisdiction) and Exequtive Partners (Luxembourg) has progressed as planned. From an organic growth perspective, we remain confident in our new business pipeline, continue to invest progressively in our global operating model and see opportunities for service development and cross-selling. Our M&A pipeline also remains strong and we see continued opportunities for acquisitive growth in attractive geographies and service lines at appropriate prices."

 

The Company will announce its interim results for the six months ending 30 June 2019 on Tuesday 17 September 2019. An analyst briefing will be given by Nigel Le Quesne, Chief Executive Officer and Martin Fotheringham, Chief Financial Officer, at 09:30 GMT at the offices of Numis Securities, 10 Paternoster Square, London EC4M 7LT.

 

An audio-cast of the presentation will be made available on the JTC website following the presentation. Those analysts wishing to attend are asked to contact David Vieira, Chief Communications Officer, on +44 (0) 1534 816 246 or david.vieira@jtcgroup.com

 

 

 

Enquiries:

 

JTC PLC +44 (0) 1534 700 000

Nigel Le Quesne, Chief Executive Officer

Martin Fotheringham, Chief Financial Officer

David Vieira, Chief Communications Officer

 

Camarco +44(0)20 3757 4985

Geoffrey Pelham-Lane

Kimberley Taylor

Monique Perks

 

About JTC

 

JTC is a global provider of fund, corporate and private wealth services to institutional and private clients. The Company has a global presence, with over 700 staff operating from a network of 20 offices and assets under administration totalling c. US$ 110 billion.

 

JTC is committed to its shared ownership culture and philosophy, with management and staff holding over 20% of the equity in the firm, clearly aligning the interests of clients, employees and other stakeholders.

 

www.jtcgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRBMITMBMTBML
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.